---
schema_version: "secwatch.filing_event.v1"
accession: "0000926326-22-000031"
form_type: "8-K"
ticker: "OMCL"
cik: "0000926326"
company_name: "OMNICELL, INC."
filed_at: "2022-11-02T23:59:59+00:00"
generated_at: "2026-06-22T16:39:27.081673+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Omnicell Q3 revenue $348M (+17% YoY); GAAP EPS $0.37; guides Q4 revenue $285M-$295M

## Summary
- GAAP net income $17M ($0.37/diluted share) vs $29M ($0.61) in Q3 2021.
- Non-GAAP net income $45M ($1.00/diluted share) vs $50M ($1.08) YoY.
- FY 2022 revenue guidance lowered to $1.284B-$1.294B; non-GAAP EPS $2.73-$2.83.
- Q4 revenue forecast $285M-$295M, down sharply from Q3's $348M.
- Cites health system capital freezes and labor shortages as headwinds; plans cost structure adjustments.

## SEC filing metadata
- accession: 0000926326-22-000031
- form_type: 8-K
- ticker: OMCL
- cik: 0000926326
- company_name: OMNICELL, INC.
- filed_at: 2022-11-02T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926326/000092632622000031/0000926326-22-000031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926326/000092632622000031/omcl-20221102.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000926326-22-000031
- JSON: https://secwatch.observer/filing/0000926326-22-000031.json
- Plain text: https://secwatch.observer/filing/0000926326-22-000031.txt

## Key facts
- Earnings Releases
  OMNICELL, INC. reported third quarter ended September 30, 2022 results: revenue $348 million, net income $17 million, or $0.37 per diluted share, EPS $1.00 per diluted share. Guidance lowered.
  - Period: third quarter ended September 30, 2022
  - Revenue: $348 million
  - Net income: $17 million, or $0.37 per diluted share
  - EPS: $1.00 per diluted share
  - Guidance: lowered
  - Result: reported results
  source text: Omnicell Announces Financial Results for Third Quarter 2022 GAAP and non-GAAP revenues of $348 million GAAP net income per diluted share of $0.37 Non-GAAP net income per diluted share of $1.00
  evidence_url: https://www.sec.gov/Archives/edgar/data/926326/000092632622000031/0000926326-22-000031-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.